9 completed, 3 unknown, 1 recruiting, 1 suspended. 14 Phase 3, 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 14 | Completed 9, Unknown 3, Recruiting 1, Suspended 1 |
| Phase 2 | 3 | Completed 1, Suspended 1, Unknown 1 |
Follow dienogest: new trials by email Literature Review of dienogest trials Research Report on dienogest
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Clinical Study to Compare Efficacy and Safety of Indinol Forto® 200 mg Capsules and Visanne 2 mg Tablets in Treatment of Endometriosis Indole-3-carbinol, Dienogest - Endometriosis | Phase 3 | Recruiting | Alcea | 290 | 2025-09-11 | 2025-09-18 |
| Comparing the Safety and Efficacy in the Use of Hormonal Therapy on Endometriosis Patients After Conservative Surgery Dienogest, Depo Medroxyprogesterone acetate, Leuprolide (as Leuprolide Acetate) - Endometriosis Ovary | Phase 3 | Completed | Universitas Diponegoro | 80 | 2023-09-04 | 2024-12-11 |
| Evaluation of Using Dienogest and N-Acetyl Cysteine on the Volume of Uterine Leiomyoma Dienogest 2 MG, N-acetyl cysteine - Uterine Leiomyoma | Phase 2 / Phase 3 | Completed | Ain Shams University | 40 | 2023-09-01 | 2024-12-16 |
| Comparisons of the Therapeutic Effects of Dienogest and Danazol on Endometriosis Dienogest, Danazol - Endometriosis | Phase 3 | Unknown | Far Eastern Memorial Hospital | 120 | 2023-02-25 | 2023-03-29 |
| A Multicenter, Non-Comparative Trial on the Contraceptive Efficacy, Safety, and Tolerability of LPRI-424, 13 Cycles LPRI424 (dienogest/ethinylestradiol) - Contraception | Phase 3 | Completed | Insud Pharma | 1034 | 2019-12-03 | 2023-11-14 |
| Efficacy of Dienogest Versus Oral Contraceptive Pills on Pain Associated With Endometriosis Dienogest 2 MG Oral Tablet, Yasmin - Endometriosis | Phase 2 / Phase 3 | Unknown | American University of Beirut Medical Center | 100 | 2017-02-07 | 2021-04-15 |
| Impact vs. Dienogest: A Combined Oral Contraceptive in the Size of Endometriomas Dienogest, Levonorgestrel - Endometriosis | Phase 2 / Phase 3 | Suspended | Fundación Santa Fe de Bogota | 50 | 2015-11-01 | 2016-11-22 |
| Dienogest Versus Luteal Phase Fluoxetine in the Management of Premenstrual Syndrome Dienogest, Fluoxetine, Placebo - Premenstrual Syndrome | Phase 3 | Unknown | Cairo University | 210 | 2015-04-01 | 2020-12-01 |
| Phase 3 Study of Dienogest for the Treatment of Endometriosis in Chinese Patients Dienogest (Visanne, BAY86-5258), Placebo - Endometriosis | Phase 3 | Completed | Bayer | 250 | 2013-03-01 | 2015-11-25 |
| Comparative Study of BAY86-5300 With an Extended Flexible Regimen for Endometriosis EE20/DRSP(BAY86-5300), Placebo, Dienogest - Endometriosis | Phase 3 | Completed | Bayer | 312 | 2012-10-01 | 2016-02-18 |
| Effect on Primary Dysmenorrhea Estradiol valerate, Dienogest (Natazia, Qlaira, BAY86-5027), Ethinyl estradiol, Levonorgestrel (Miranova), Placebo Match to SH T00658ID - Primary Dysmenorrhea | Phase 3 | Completed | Bayer | 507 | 2009-04-01 | 2015-08-24 |
| To Compare SH T00658ID Over Ortho Tri-Cyclen Lo (US/Canada) Estradiol valerate, Dienogest (Natazia, Qlaira, BAY86-5027), Ortho Tri Cyclen Lo - Contraception | Phase 3 | Completed | Bayer | 409 | 2008-09-08 | 2024-11-20 |
| Efficacy and Safety Study for the Treatment of Dysfunctional Uterine Bleeding Estradiol valerate/Dienogest (Natazia, Qlaira, BAY86-5027), Placebo - Metrorrhagia | Phase 3 | Completed | Bayer | 231 | 2006-02-01 | 2014-12-30 |
| Efficacy and Safety Study for the Treatment of Dysfunctional Uterine Bleeding Estradiol valerate/Dienogest (Natazia, Qlaira, BAY86-5027), Placebo - Metrorrhagia | Phase 3 | Completed | Bayer | 190 | 2005-12-01 | 2013-11-27 |
Endometriosis (6) · Metrorrhagia (2) · Myofibroma (1) · Pelvic Pain (1) · Premenstrual Syndrome (1)
Bayer (6) · Ain Shams University (1) · Alcea (1) · American University of Beirut Medical Center (1) · Cairo University (1) · Far Eastern Memorial Hospital (1) · Fundación Santa Fe de Bogota (1) · Insud Pharma (1) · Universitas Diponegoro (1)
United States (4) · Canada (3) · Egypt (2) · Germany (2) · Australia (1) · Chile (1) · China (1) · Colombia (1) · Czechia (1) · Finland (1) · Hungary (1) · Indonesia (1) · Italy (1) · Japan (1) · Lebanon (1)
Amr Mahmoud, lecturer (1) · Antoine Abu Musa, MD (1) · Enrico Colli, MD (1) · Yuli Trisetiyono, SpOG (K) (1)
PMID 21774563, PMID 22240178, PMID 18653184, PMID 21422847, PMID 21784734, PMID 22927764, PMID 23439617, PMID 23638631, PMID 24713413, PMID 28911925, PMID 30461337, PMID 34826668, PMID 37523477
2005 (1), 2008 (1)